Publications for Peter Gunnarsson
Co-author map based on ISI articles 2007-
Journal Articles
Knut Fälker, Linda Haglund, Peter Gunnarsson, Martina Nylander, Tomas Lindahl and Magnus Grenegård
Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets
Biochemical Journal, 2011, 436, 469-480.
Web of Science® Times Cited: 6 |
Peter Gunnarsson, Louise Fornander, Peter Påhlsson and Magnus Grenegård
Sialic acid residues play a pivotal role in alpha(1)-acid glycoprotein (AGP)-induced generation of reactive oxygen species in chemotactic peptide pre-activated neutrophil granulocytes
INFLAMMATION RESEARCH, 2010, 59(2), 89-95.
Web of Science® Times Cited: 1 |
Peter Gunnarsson, Louise Levander, Peter Påhlsson and Magnus Grenegård
α1-acid glycoprotein (AGP)-induced platelet shape change involvesthe Rho/Rho kinase signalling pathway
Thrombosis and Haemostasis, 2009, , .
Web of Science® Times Cited: 2 |
Peter Gunnarsson, Louise Levander, Peter Påhlsson and Magnus Grenegård
The acute-phase protein alpha 1-acid glycoprotein (AGP) induces rises in cytosolic Ca2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs)
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007, 21(14), 4059-4069.
Web of Science® Times Cited: 19 |
Anna Asplund Persson, Peter Gunnarsson, Eva Lindström and Magnus Grenegård
Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries
European Journal of Pharmacology, 2005, 521(1-3), 124-132.
Web of Science® Times Cited: 1 |
Anna K Asplund Persson, Louise Palmér, Peter Gunnarsson and Magnus Grenegård
Characterisation of GEA 3175 on human platelets: comparison with S-nitroso-N-acetyl-D,L-penicillamine
European Journal of Pharmacology, 2004, 496(1-3), 1-9.
Web of Science® Times Cited: 8 |
Conference Articles
Ph.D. Theses
Ph.D., Lic. Theses
